Works matching IS 13524585 AND DT 2015

Results: 265

Cognitive impairment in Chinese neuromyelitis optica.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1839, doi. 10.1177/1352458515576982

By:

Zhang, N.;
Li, Y. J.;
Fu, Y.;
Shao, J. H.;
Luo, L. L.;
Yang, L.;
Shi, F. D.;
Liu, Y.

Publication type:

Article

Progressive cerebral atrophy in neuromyelitis optica.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1872, doi. 10.1177/1352458515600246

By:

Yoko Warabi;
Toshiyuki Takahashi;
Eiji Isozaki

Publication type:

Article

The occurrence of dystonia in upper-limb multiple sclerosis tremor.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1847, doi. 10.1177/1352458515577690

By:

Van der Walt, A.;
Buzzard, K.;
Sung, S.;
Spelman, T.;
Kolbe, S. C.;
Marriott, M.;
Butzkueven, H.;
Evans, A.

Publication type:

Article

FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1811, doi. 10.1177/1352458515574895

By:

Luessi, Felix;
Kraus, Stefan;
Trinschek, Bettina;
Lerch, Steffen;
Ploen, Robert;
Paterka, Magdalena;
Roberg, Torsten;
Poisa-Beiro, Laura;
Klotz, Luisa;
Wiendl, Heinz;
Bopp, Tobias;
Jonuleit, Helmut;
Jolivel, Valérie;
Zipp, Frauke;
Witsch, Esther

Publication type:

Article

Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1865, doi. 10.1177/1352458514544078

By:

Sonder, Judith M.;
Balk, Lisanne J.;
van der Linden, Femke A. H.;
Bosma, Libertje V. A. E.;
Polman, Chris H.;
Uitdehaag, Bernard M. J.

Publication type:

Article

Anti-JC virus antibody titres increase over time with natalizumab treatment.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1833, doi. 10.1177/1352458515599681

By:

Raffel, J.;
Gafson, A. R.;
Malik, O.;
Nicholas, R.

Publication type:

Article

A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1781, doi. 10.1177/1352458515578888

By:

Outteryck, Olivier;
Majed, Bilal;
Defoort-Dhellemmes, Sabine;
Vermersch, Patrick;
Zéphir, Hélène

Publication type:

Article

Should we systematically test patients with clinically isolated syndrome for auto-antibodies?

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1802, doi. 10.1177/1352458515575338

By:

Negrotto, Laura;
Tur, Carmen;
Tintoré, Mar;
Arrambide, Georgina;
Sastre-Garriga, Jaume;
Río, Jordi;
Comabella, Manuel;
Nos, Carlos;
Galán, Ingrid;
Vidal-Jordana, Angela;
Simon, Eva;
Castilló, Joaquín;
Palavra, Filipe;
Mitjana, Raquel;
Auger, Cristina;
Rovira, Àlex;
Montalban, Xavier

Publication type:

Article

Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1761, doi. 10.1177/1352458515574148

By:

Modvig, S.;
Degn, M.;
Roed, H.;
Sørensen, T. L.;
Larsson, H. B. W.;
Langkilde, A. R.;
Frederiksen, J. L.;
Sellebjerg, F.

Publication type:

Article

Secondary progressive NMO, or concomitant NMO and a primary neurodegenerative disorder?

Published in:

2015

By:

Rovira, Alex;
Tur, Carmen;
Montalban, Xavier

Publication type:

Opinion

Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1823, doi. 10.1177/1352458515576984

By:

Kohlmann, Rebekka;
Salmen, Anke;
Chan, Andrew;
Knabbe, Cornelius;
Diekmann, Jürgen;
Brockmeyer, Norbert;
Skaletz-Rorowski, Adriane;
Michalik, Claudia;
Gold, Ralf;
Überla, Klaus

Publication type:

Article

The relationship between cognitive function and high-resolution diffusion tensor MRI of the cingulum bundle in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1794, doi. 10.1177/1352458515576983

By:

Koenig, Katherine A.;
Sakaie, Ken E.;
Lowe, Mark J.;
Jian Lin;
Stone, Lael;
Bermel, Robert A.;
Beall, Erik B.;
Rao, Stephen M.;
Trapp, Bruce D.;
Phillips, Micheal D.

Publication type:

Article

Low JC virus antibody index during natalizumab treatment less safe than assumed?

Published in:

2015

By:

Killestein, Joep;
Wattjes, Mike P.

Publication type:

Editorial

What to make of cannabis and cognition in MS: In search of clarity amidst the haze.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1755, doi. 10.1177/1352458515607652

By:

Feinstein, Anthony;
Banwell, Emma;
Pavisian, Bennis

Publication type:

Article

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1856, doi. 10.1177/1352458515578770

By:

Cortese, Marianna;
Riise, Trond;
Bjørnevik, Kjetil;
Holmøy, Trygve;
Kampman, Margitta T.;
Magalhaes, Sandra;
Pugliatti, Maura;
Wolfson, Christina;
Myhr, Kjell-Morten

Publication type:

Article

Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1632, doi. 10.1177/1352458515599848

By:

Costa, C.;
Martínez-Sáez, E.;
Gutiérrez-Franco, A.;
Eixarch, H.;
Castro, Z.;
Ortega-Aznar, A.;
Ramón y Cajal, S.;
Montalban, X.;
Espejo, C.

Publication type:

Article

Corticospinal tract integrity is related to primary motor cortex thinning in relapsing--remitting multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1771, doi. 10.1177/1352458515576985

By:

Bergsland, Niels;
Laganà, Maria Marcella;
Tavazzi, Eleonora;
Caffini, Matteo;
Tortorella, Paola;
Baglio, Francesca;
Baselli, Giuseppe;
Rovaris, Marco

Publication type:

Article

Neurodegeneration in multiple sclerosis is a process separate from inflammation: No.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1628, doi. 10.1177/1352458515612244

By:

Hutchinson, Michael

Publication type:

Article

Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1655, doi. 10.1177/1352458515573094

By:

Haines, Jeffery D.;
Vidaurre, Oscar G.;
Zhang, Fan;
Riffo-Campos, Ángela L.;
Castillo, Josefa;
Casanova, Bonaventura;
Casaccia, Patrizia;
Lopez-Rodas, Gerardo

Publication type:

Article

Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.

Published in:

2015

By:

Kremer, David;
Hartung, Hans-Peter;
Küry, Patrick

Publication type:

Editorial

MS Research Australia Progress in MS Research 2015 Conference 29-30 October, 2015 Melbourne, Australia.

Published in:: 2015
Publication type:: Abstract

Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1626, doi. 10.1177/1352458515587598

By:

Louapre, Céline;
Lubetzki, Catherine

Publication type:

Article

Physical activity and pediatric multiple sclerosis: Developing a research agenda.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1618, doi. 10.1177/1352458515606526

By:

Yeh, E. Ann;
Kinnett-Hopkins, Dominique;
Grover, Stephanie A.;
Motl, Robert W.

Publication type:

Article

A case of relapsing–remitting tumour-like inflammation of the central nervous system.

Published in:

2015

By:

Miante, Silvia;
Perini, Paola;
Rinaldi, Francesca;
Gallo, Paolo

Publication type:

Case Study

Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?

Published in:

2015

By:

Weinshenker, Brian G.

Publication type:

Opinion

Role of membrane complement regulators in neuromyelitis optica.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1644, doi. 10.1177/1352458515571446

By:

Saadoun, Samira;
Papadopoulos, Marios C.

Publication type:

Article

Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1713, doi. 10.1177/1352458515570768

By:

Prosperini, Luca;
Annovazzi, Pietro;
Capobianco, Marco;
Capra, Ruggero;
Buttari, Fabio;
Gasperini, Claudio;
Galgani, Simonetta;
Solaro, Claudio;
Centonze, Diego;
Bertolotto, Antonio;
Pozzilli, Carlo;
Ghezzi, Angelo

Publication type:

Article

Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1705, doi. 10.1177/1352458514567727

By:

Hulst, Hanneke E.;
Schoonheim, Menno M.;
Van Geest, Quinten;
Uitdehaag, Bernard M. J.;
Barkhof, Frederik;
Geurts, Jeroen J. G.

Publication type:

Article

Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1693, doi. 10.1177/1352458515569098

By:

Reich, Daniel S.;
White, Richard;
Cortese, Irene C. M.;
Vuolo, Luisa;
Shea, Colin D.;
Collins, Tassie L.;
Petkau, John

Publication type:

Article

Functional connectivity changes and their relationship with clinical disability and white matter integrity in patients with relapsing–remitting multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1681, doi. 10.1177/1352458514568826

By:

Sbardella, Emilia;
Tona, F.;
Petsas, N.;
Upadhyay, N.;
Piattella, M. C.;
Filippini, N.;
Prosperini, L.;
Pozzilli, C.;
Pantano, P.

Publication type:

Article

Burden of risk variants correlates with phenotype of multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1670, doi. 10.1177/1352458514568174

By:

Hilven, Kelly;
Patsopoulos, Nikolaos A.;
Dubois, Bénédicte;
Goris, An

Publication type:

Article

Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1723, doi. 10.1177/1352458514568173

By:

Voldsgaard, A.;
Bager, P.;
Garde, E.;
Åkeson, P.;
Leffers, A. M.;
Madsen, C. G.;
Kapel, C.;
Roepstorff, A.;
Thamsborg, S. M.;
Melbye, M.;
Siebner, H.;
Søndergaard, H. B.;
Sellebjerg, F.;
Sørensen, P. Soelberg

Publication type:

Article

Sources and level of income among individuals with multiple sclerosis compared to the general population: A nationwide population-based study.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1730, doi. 10.1177/1352458515570767

By:

Wiberg, Michael;
Friberg, Emilie;
Stenbeck, Magnus;
Alexanderson, Kristina;
Norlund, Anders;
Hillert, Jan;
Tinghög, Petter

Publication type:

Article

Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1485, doi. 10.1177/1352458515601513

By:

Plemel, Jason R.;
Juzwik, Camille A.;
Benson, Curtis A.;
Monks, Michael;
Harris, Chelsea;
Ploughman, Michelle

Publication type:

Article

Biotin and demyelinating diseases – a new connection?

Published in:

2015

By:

Tourbah, Ayman

Publication type:

Opinion

Uniform guidelines for reporting COI within industry-sponsored clinical trials (ISCT).

Published in:

2015

By:

Hussey, Valerie

Publication type:

Opinion

Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1604, doi. 10.1177/1352458515596457

By:

Bottin, Laure;
Prud’hon, Sabine;
Guey, Stéphanie;
Giannesini, Claire;
Wolf, Barry;
Pindolia, Kirit;
Stankoff, Bruno

Publication type:

Article

Uhthoff questioned.

Published in:

2015

By:

Pryse-Phillips, William E. M.;
Sloka, J. Scott

Publication type:

Editorial

Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1593, doi. 10.1177/1352458515569101

By:

Solomon, Andrew J.;
Klein, Eran P.;
Corboy, John R.;
Bernat, James L.

Publication type:

Article

Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1600, doi. 10.1177/1352458514567728

By:

Vennegoor, Anke;
van Rossum, Johannis A.;
Polman, Chris H.;
Wattjes, Mike P.;
Killestein, Joep

Publication type:

Article

Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1557, doi. 10.1177/1352458514566417

By:

Olsson, A.;
Oturai, D. B.;
Sørensen, P. S.;
Oturai, P. S.;
Oturai, A. B.

Publication type:

Article

Unilateral and bilateral upper limb dysfunction at body functions, activity and participation levels in people with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1566, doi. 10.1177/1352458514567553

By:

Bertoni, Rita;
Lamers, Ilse;
Chen, Christine C.;
Feys, Peter;
Cattaneo, Davide

Publication type:

Article

Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1533, doi. 10.1177/1352458514567215

By:

Muls, Nathalie G. V.;
Dang, Hong Anh;
Sindic, Christian J. M.;
van Pesch, Vincent

Publication type:

Article

Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1513, doi. 10.1177/1352458514566666

By:

Ketelslegers, Immy A.;
Van Pelt, Daniëlle E.;
Bryde, Susanne;
Neuteboom, Rinze F.;
Catsman-Berrevoets, Coriene E.;
Hamann, Dörte;
Hintzen, Rogier Q.

Publication type:

Article

Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1498, doi. 10.1177/1352458514566418

By:

Lopez de Lapuente, Aitzkoa;
Pinto-Medel, María Jesús;
Astobiza, Ianire;
Alloza, Iraide;
Comabella, Manuel;
Malhotra, Sunny;
Montalban, Xavier;
Zettl, Uwe K.;
Rodríguez-Antigüedad, Alfredo;
Fernández, Oscar;
Vandenbroeck, Koen

Publication type:

Article

The influence of cognitive dysfunction on benefit from learning and memory rehabilitation in MS: A sub-analysis of the MEMREHAB trial.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1575, doi. 10.1177/1352458514567726

By:

Chiaravalloti, Nancy D.;
DeLuca, John

Publication type:

Article

The high cost of spasticity in multiple sclerosis to individuals and society.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1583, doi. 10.1177/1352458514566416

By:

Stevenson, V. L.;
Gras, A.;
Bárdos, J. I.;
Broughton, J.

Publication type:

Article

Multiple sclerosis relapse phenotype is an important, neglected determinant of disease-outcome: Commentary.

Published in:

2015

By:

Hutchinson, Michael

Publication type:

Opinion

Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1521, doi. 10.1177/1352458514564589

By:

Haas, Jürgen;
Schwarz, Alexander;
Korporal-Kunke, Mirjam;
Jarius, Sven;
Wiendl, Heinz;
Kieseier, Bernd C.;
Wildemann, Brigitte

Publication type:

Article

Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome – YES.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 11, p. 1369, doi. 10.1177/1352458515608263

By:

Scott, Thomas F.

Publication type:

Article